Elsevier supports the need for authors to share, disseminate and maximize the impact of their research. We take our responsibility as stewards of the online record seriously, and work to ensure our policies and procedures help to protect the integrity of scholarly works.
Author's rights to reuse and post their own articles published by Elsevier are defined by Elsevier's copyright policy. For our proprietary titles, the type of copyright agreement used depends on the author's choice of publication:
For subscription articles: These rights are determined by a copyright transfer, where authors retain scholarly rights to post and use their articles.
For open access articles: These rights are determined by an exclusive license agreement, which applies to all our open access content.
In both cases, the fundamental rights needed to publish and distribute an article remain the same and Elsevier authors will be able to use their articles for a wide range of scholarly purposes.
Details on how authors can reuse and post their own articles are provided below.
Help and support
For reuse and posting not detailed below, please see our posting policy, or for authors who would like to:
- Include material from other sources in your work being published by Elsevier, please visit: Permission seeking guidelines for Elsevier authors.
- Obtain permission to re-use material from Elsevier books, journals, databases, or other products, please visit: Obtaining permission to reuse Elsevier material
- Or if you are an Elsevier author and are contacted by a requestor who wishes to re-use all or part of your article or chapter, please also refer them to our Obtaining Permission to Re-Use Elsevier Material page.
- See our FAQ on posting and copyright queries.
- Contact us directly, please email our Permissions Help Desk.
Content DIV 111710
Content DIV 111710
How authors can use their own journal articles
Authors can use their articles for a wide range of scholarly, non-commercial purposes as outlined below. These rights apply for all Elsevier authors who publish their article as either a subscription article or an open access article.
We require that all Elsevier authors always include a full acknowledgement and, if appropriate, a link to the final published version hosted on Science Direct.
For open access articles these rights are separate from how readers can reuse your article as defined by the author's choice of Creative Commons user license options.
|Authors can use either their accepted author manuscript or final published article for:|
|Use at a conference, meeting or for teaching purposes|
|Internal training by their company|
|Sharing individual articles with colleagues for their research use* (also known as 'scholarly sharing')|
|Use in a subsequent compilation of the author's works|
|Inclusion in a thesis or dissertation|
|Reuse of portions or extracts from the article in other works|
|Preparation of derivative works (other than for commercial purposes)|
How authors can post their articles online
Elsevier authors can share and post their articles online in a variety of ways. For specific details please see our posting policy.
If your institution has an open access policy or mandate that requires you to post, Elsevier requires an agreement to be in place which respects the journal-specific embargo periods. Please see our institutional and funding body agreements for further details.
|Posting||Subscription article||Open access article|
|Accepted Author |
|Published Journal Article||Pre-print Version||Accepted Author |
|Published Journal Article|
|Posting to a pre-print server.*|| |
(except when posting to arXiv)
|Voluntary posting on open web sites operated by author or author's institution for scholarly purposes.|
|Mandated deposit or deposit in or posting to subject-oriented or centralized repositories.|
|Use or posting for commercial gain or to substitute for services provided directly by journal.||Only under CC BY||Only under CC BY||Only under CC BY|
|Posting raw research data to a repository.**|
**Note: Raw data is different from the figures, tables, etc. published within the article that may represent the same research data but for which are copyrighted.
Key definitions explained
Please find below a list of key terminology used in our Elsevier policies:
- Pre-print Definition: A pre-print is an author's own write-up of research results and analysis that has not been peer-reviewed, nor had any other value added to it by a publisher (such as formatting, copy editing, technical enhancement, etc.).
- Accepted Author Manuscript (AAM) Definition: An accepted author manuscript (AAM) is the author's version of the manuscript of an article that has been accepted for publication and which may include any author-incorporated changes suggested through the processes of submission, peer review and editor-author communications. AAMs do not include other publisher value-added contributions such as copy-editing, formatting, technical enhancements and (if relevant) pagination.
- Published Journal Article (PJA) Definition: A published journal article (PJA) is the definitive final record of published research that appears or will appear in the journal and embodies all value-adding publisher activities including copy-editing, formatting and (if relevant) pagination.
Commercial use/purpose means: the use or posting for commercial gain, whether for a fee or for free, or to substitute for the services provided directly by the journal including:
The posting by companies of their employee - authored works for use by customers of such companies (e.g. pharmaceutical companies and physician - prescribers)
Commercial exploitation such as directly associating advertising with such posting or the charging of fees for document delivery or access.
Systematic distribution means: policies or other mechanisms designed to aggregate and openly disseminate, or to substitute for journal-provided services, including:
- The systematic distribution to others via e-mail lists or list servers (to parties other than known colleagues), whether for a fee or for free;
- The posting of links to articles by commercial third parties including pharmaceutical companies; and institutional, funding body or government manuscript posting policies or mandates that aim to aggregate and openly distribute the work by its researchers or funded researchers; and
- Subject repositories that aim to aggregate and openly distribute AAMs authored by researchers in specific subject areas.